Iacopo Petrini
Iacopo Petrini
Verified email at unipi.it
Cited by
Cited by
PTEN expression and KRAS mutations on primary tumors and metastases in the prediction of benefit from cetuximab plus irinotecan for patients with metastatic colorectal cancer
F Loupakis, L Pollina, I Stasi, A Ruzzo, M Scartozzi, D Santini, G Masi, ...
Journal of clinical oncology 27 (16), 2622-2629, 2009
MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non–small cell lung carcinoma
J Voortman, A Goto, J Mendiboure, JJ Sohn, AJ Schetter, M Saito, ...
Cancer research 70 (21), 8288-8298, 2010
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors
I Petrini, PS Meltzer, IK Kim, M Lucchi, KS Park, G Fontanini, J Gao, ...
Nature genetics 46 (8), 844-849, 2014
Thymic malignancies: from clinical management to targeted therapies
RJ Kelly, I Petrini, A Rajan, Y Wang, G Giaccone
Journal of clinical oncology 29 (36), 4820, 2011
PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC
M Del Re, R Marconcini, G Pasquini, E Rofi, C Vivaldi, F Bloise, ...
British journal of cancer 118 (6), 820-824, 2018
Biology of MET: a double life between normal tissue repair and tumor progression
I Petrini
Annals of translational medicine 3 (6), 2015
Mutations of epigenetic regulatory genes are common in thymic carcinomas
Y Wang, A Thomas, C Lau, A Rajan, Y Zhu, JK Killian, I Petrini, T Pham, ...
Scientific reports 4 (1), 1-11, 2014
Contribution of KRAS mutations and c. 2369C> T (p. T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNA
M Del Re, M Tiseo, P Bordi, A D'Incecco, A Camerini, I Petrini, M Lucchesi, ...
Oncotarget 8 (8), 13611, 2017
Phase II trial of sorafenib in combination with 5-fluorouracil infusion in advanced hepatocellular carcinoma
I Petrini, M Lencioni, M Ricasoli, M Iannopollo, C Orlandini, F Oliveri, ...
Cancer chemotherapy and pharmacology 69 (3), 773-780, 2012
Are MSCs angiogenic cells? New insights on human nestin-positive bone marrow-derived multipotent cells
S Pacini, I Petrini
Frontiers in cell and developmental biology 2, 20, 2014
Insulin‐like growth factor‐1 receptor and phosphorylated AKT‐serine 473 expression in 132 resected thymomas and thymic carcinomas
PA Zucali, I Petrini, E Lorenzi, M Merino, L Cao, L Di Tommaso, HS Lee, ...
Cancer 116 (20), 4686-4695, 2010
Copy number aberrations of BCL2 and CDKN2A/B identified by array-CGH in thymic epithelial tumors
I Petrini, PS Meltzer, PA Zucali, J Luo, C Lee, A Santoro, HS Lee, ...
Cell death & disease 3 (7), e351-e351, 2012
Expression and mutational status of c-kit in thymic epithelial tumors
I Petrini, PA Zucali, HS Lee, MA Pineda, PS Meltzer, B Walter-Rodriguez, ...
Journal of Thoracic Oncology 5 (9), 1447-1453, 2010
A multicenter phase II study of the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancer
E Vasile, G Masi, L Fornaro, S Cupini, F Loupakis, S Bursi, I Petrini, ...
British journal of cancer 100 (11), 1720-1724, 2009
Lower airway inflammation before and after house dust mite nasal challenge: an age and allergen exposure-related phenomenon
F Marcucci, G Passalacqua, GW Canonica, F Frati, S Salvatori, I Petrini, ...
Respiratory medicine 101 (7), 1600-1608, 2007
The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer
HR Fernandez, SM Gadre, M Tan, GT Graham, R Mosaoa, MS Ongkeko, ...
Cell Death & Differentiation 25 (7), 1239-1258, 2018
Evaluation of PTEN expression in colorectal cancer (CRC) metastases (mets) and in primary tumors as predictors of activity of cetuximab plus irinotecan treatment
F Loupakis, L Pollina, I Stasi, G Masi, N Funel, M Scartozzi, I Petrini, ...
Journal of Clinical Oncology 26 (15_suppl), 4003-4003, 2008
Loss of 18q22. 3 involving the carboxypeptidase of glutamate-like gene is associated with poor prognosis in resected pancreatic cancer
JH Lee, E Giovannetti, JH Hwang, I Petrini, Q Wang, J Voortman, Y Wang, ...
Clinical Cancer Research 18 (2), 524-533, 2012
Reproducibility of the WHO classification of thymomas: practical implications
PA Zucali, L Di Tommaso, I Petrini, S Battista, HS Lee, M Merino, ...
Lung Cancer 79 (3), 236-241, 2013
Mesenchymal cells inhibit expansion but not cytotoxicity exerted by gamma–delta T cells
I Petrini, S Pacini, M Petrini, R Fazzi, L Trombi, S Galimberti
European journal of clinical investigation 39 (9), 813-818, 2009
The system can't perform the operation now. Try again later.
Articles 1–20